XOMA Royalty completes acquisition of Mural Oncology Dec 5, 2025 07:45AM
Irish court approves XOMA Royalty's acquisition of Mural Oncology Dec 3, 2025 04:32PM
Mural Oncology sets final cash payout at $2.035 per share for XOMA deal Nov 26, 2025 09:00AM
Mural Oncology shareholders approve XOMA Royalty acquisition Oct 24, 2025 04:26PM
XOMA to acquire Mural Oncology for up to $2.24 per share in cash Aug 20, 2025 08:30AM


Aug 20, 2025 08:25AM Mural Oncology (MURA) Halted, News Pending
Apr 15, 2025 12:33PM Mural Oncology (MURA) PT Lowered to $4 at Raymond James
Apr 15, 2025 08:01AM Mural Oncology (MURA) Announces Plans to Explore Strategic Alternatives
Mar 26, 2025 06:47AM Mural Oncology (MURA) PT Lowered to $6 at H.C. Wainwright
Mar 25, 2025 12:52PM Morgan Stanley Downgrades Mural Oncology (MURA) to Equalweight
Mar 25, 2025 11:35AM Raymond James Downgrades Mural Oncology (MURA) to Outperform
Mar 25, 2025 07:36AM Jones Trading Downgrades Mural Oncology (MURA) to Hold
Mar 25, 2025 06:30AM Mural Oncology (MURA) Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA
Mar 12, 2025 06:35AM Mural Oncology (MURA) Misses Q4 EPS by 201c
Jan 27, 2025 06:50AM Jones Trading Starts Mural Oncology (MURA) at Buy
Nov 13, 2024 04:34PM Mural Oncology plc (MURA) Tops Q3 EPS by 10c
Nov 13, 2024 04:12PM Mural Oncology (MURA) Files $300M Mixed Shelf
Oct 17, 2024 06:05AM H.C. Wainwright Starts Mural Oncology (MURA) at Buy
Oct 4, 2024 06:29AM Raymond James Starts Mural Oncology (MURA) at Strong Buy
Sep 23, 2024 07:02AM Mural Oncology (MURA) Strengthens Board of Directors with the Appointment of Sachiyo Minegishi
Jul 31, 2024 07:03AM Mural Oncology (MURA) Appoints George Golumbeski to its Board